Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya: A qualitative study.
Hepatitis C (HCV) disproportionately affects people who inject drugs (PWID). Despite availability of safe and effective treatment, HCV treatment access and uptake among PWID in low- and middle-income countries (LMICs) has been limited. Understanding the lived experiences of PWID in these settings wh...
Saved in:
Main Authors: | Hannah N Manley, Lindsey R Riback, Mercy Nyakowa, Matthew J Akiyama, Peter Cherutich, John Lizcano, Ann Kurth, Abbe Muller |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLOS Global Public Health |
Online Access: | https://doi.org/10.1371/journal.pgph.0003284 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya: A qualitative study
by: Hannah N. Manley, et al.
Published: (2025-01-01) -
Lived experiences and perspectives of women who had undergone perinatal loss in Nairobi county, Kenya: a qualitative study
by: Emily Wanja Kaburu, et al.
Published: (2024-08-01) -
Serious Bacterial Infections and Hepatitis C Virus Among People Who Inject Drugs: A Syndemic or Intertwined Epidemics?
by: Thomas J. Stopka, et al.
Published: (2025-01-01) -
Hepatitis C Virus Seroconversion among Hiv-Positive Men Who Have Sex with Men with No History of Injection Drug Use: Results from a Clinical Hiv Cohort
by: Ann N Burchell, et al.
Published: (2015-01-01) -
Patients with Chronic Hepatitis C - Who Should Not Be Treated?
by: Andreas Schüler, et al.
Published: (2000-01-01)